As of April 2025 KOBAYASHI Pharmaceutical has a market cap of โน233.40 Billion. This makes KOBAYASHI Pharmaceutical the world's 3530th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โน233.40 B | -8.84% |
2024 | โน256.02 B | -13.93% |
2023 | โน297.44 B | -29.97% |
2022 | โน424.72 B | -6.57% |
2021 | โน454.57 B | -34.97% |
2020 | โน699.01 B | 47.29% |
2019 | โน474.58 B | 26.78% |
2018 | โน374.34 B | 14.59% |
2017 | โน326.68 B | 35.19% |
2016 | โน241.65 B | 7.79% |
2015 | โน224.19 B | 46.59% |
2014 | โน152.94 B | 8.07% |
2013 | โน141.51 B | 32.33% |
2012 | โน106.93 B | -5.34% |
2011 | โน112.96 B | 33.07% |
2010 | โน84.89 B | 11.6% |
2009 | โน76.07 B | -12.14% |
2008 | โน86.58 B | 38.58% |
2007 | โน62.48 B | -8.45% |
2006 | โน68.24 B |
On Apr 5th, 2025 the market cap of KOBAYASHI Pharmaceutical was reported to be: